Chewawiwat N, Lulitanond V, Nimmanahaeminda K, Thamprasert K, Nicomrat D, Ponglikitmongkol M
Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, Thailand.
Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:329-32.
Among various methods which have been developed for facilitating the screening of point mutations in human genomic DNA, PCR-Primer Introduced Restriction Analysis (PCR-PIRA) is of particular interest due to its practicality and short procedure allowing detection of point mutations by simple restriction enzyme digestion directly after PCR amplification. However, one limitation of PCR-PIRA method is the absence of restriction sites in the region of detection, thus creation of the recognition site in primers has been introduced. Detection of a point mutation at codon 12 in K-ras oncogene by BstNI requires one base change in the primer sequence so that only the normal but not mutant PCR product will be digested by the enzyme. However, false positive results generated from undigested normal DNA sequence are always obtained. This effect is compounded when it is used to analyse mixed cell populations in paraffin embedded section of cancer cells. Assay of a mutant band generated from normal DNA by densitometric quantitation enabled the determination of background values and thereby eliminated false positive results. Samples with higher ratios between mutant and normal bands than the background one after the first PCR-PIRA would be subjected to the second PCR-PIRA in order to confirm the results. Screening of such mutations in cervical carcinomas from paraffin embedded sections using the above criteria should reduce misinterpretation of PCR-PIRA results.
在已开发的用于促进人类基因组DNA中点突变筛选的各种方法中,PCR-引物引入限制性分析(PCR-PIRA)因其实用性和简短的操作流程而备受关注,该流程允许在PCR扩增后直接通过简单的限制性酶切来检测点突变。然而,PCR-PIRA方法的一个局限性是检测区域内不存在限制性位点,因此引入了在引物中创建识别位点的方法。通过BstNI检测K-ras癌基因第12密码子处的点突变需要引物序列中有一个碱基变化,这样只有正常而非突变的PCR产物会被该酶消化。然而,总是会得到未消化的正常DNA序列产生的假阳性结果。当用于分析癌细胞石蜡包埋切片中的混合细胞群体时,这种影响会更加复杂。通过光密度定量分析正常DNA产生的突变条带能够确定背景值,从而消除假阳性结果。在第一次PCR-PIRA后,突变带与正常带的比率高于背景值的样本将进行第二次PCR-PIRA以确认结果。使用上述标准从石蜡包埋切片中筛选宫颈癌中的此类突变应减少对PCR-PIRA结果的错误解读。